Puma Biotechnology
PBYI
PBYI
133 hedge funds and large institutions have $2.52B invested in Puma Biotechnology in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 59 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
18% less funds holding
Funds holding: 163 → 133 (-30)
31% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 59
62% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 47
Holders
133
Holding in Top 10
2
Calls
$67.1M
Puts
$32.8M
Top Buyers
| 1 | +$95.9M | |
| 2 | +$81.8M | |
| 3 | +$79.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.6M |
Top Sellers
| 1 | -$52.3M | |
| 2 | -$49M | |
| 3 | -$24M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$16.7M |
| 5 |
JP Morgan Chase
New York
|
-$14.9M |